Different central effects of the 5-HT antagonists mianserine and cyproheptadine.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D003533:Cyproheptadine / Q000494:pharmacology* / Q000633:toxicity; D003984:Dibenzazepines / Q000494:pharmacology* / Q000633:toxicity; D004336:Drug Antagonism; D004597:Electroshock; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010862:Pilocarpine / Q000037:antagonists & inhibitors; D011719:Pyrazines / Q000494:pharmacology* / Q000633:toxicity; D012110:Reserpine / Q000494:pharmacology; D012472:Salivation / Q000187:drug effects; D012640:Seizures / Q000517:prevention & control; D012702:Serotonin Antagonists; D013331:Strychnine / Q000037:antagonists & inhibitors; D014203:Tremorine / Q000037:antagonists & inhibitors
D003984:Dibenzazepines; D011719:Pyrazines; D012702:Serotonin Antagonists; D010862:Pilocarpine; D003533:Cyproheptadine; D012110:Reserpine; D013331:Strychnine; D014203:Tremorine; D010433:Pentylenetetrazole